Explore the potential of SGLT2 inhibitors for IgAN. Learn how these diabetes drugs slow kidney damage progression when added to standard treatment.

We tapped experts to weigh in on the latest findings.

Chronic kidney disease (CKD) affects nearly 36 million people. “CKD is a real public health crisis, and one that’s steadily rising,” said Merlin Thomas, M.B.Ch.B., Ph.D., FRACP, a professor of ...

A fast-aging fish is giving scientists a rare, accelerated look at how kidneys grow old—and how a common drug may slow that ...

Medically reviewed by Michael Menna, DO Complement 3 glomerulopathy is a rare disease caused by a buildup of proteins in the kidneys. The prognosis and life expectancy for C3G depends on the disease ...

Healthy kidneys are essential for detoxification, blood pressure regulation, and electrolyte balance. Adequate hydration and ...

Patients with immunoglobin A nephropathy who reached complete remission of proteinuria with sparsentan had greater eGFR ...

Chronic kidney disease (CKD) involves the progressive loss of kidney function. Jen Hernandez, a registered dietitian board certified in renal nutrition, explains why working with a dietary expert is a ...

In a new study published in Kidney International, researchers report that drugs known as SGLT2 inhibitors prevented ...

Polycystic kidney disease (PKD) causes round, fluid-filled sacs called cysts to grow in your kidneys. These cysts can cause your kidneys to enlarge and function poorly. People with PKD can also ...

Scientists find how changes in bile acids linked to gut bacteria may signal advancing chronic kidney disease, pointing to a possible link between gut metabolism and kidney decline ...